开发包膜蛋白抗原以血清学区分寨卡病毒感染与登革病毒感染
本研究基于寨卡病毒包膜蛋白的比较表位建模,设计了展示E蛋白结构域I(Z-EDI)和结构域III(Z-EDIII)独特抗原区的两种重组抗原。Z-EDI和Z-EDIII抗原在感染后>12周的恢复期晚期能一致检测寨卡病毒特异性IgG,而不与登革病毒免疫血清交叉反应;但在感染后2至12周的恢复期早期,部分登革病毒免疫血清与这两种抗原有交叉反应。Z-EDIII抗原有望作为诊断抗原用于人群监测和检测既往感染。
要点
- Z-EDI和Z-EDIII抗原在感染后>12周可特异性检测寨卡病毒IgG,不与登革病毒血清交叉反应。
- 感染后2至12周恢复期早期,部分登革病毒免疫血清与Z-EDI和Z-EDIII抗原有交叉反应。
- Z-EDIII抗原交叉反应在恢复期早期达峰并随时间迅速下降,有潜力用于既往感染检测。
核心结论
- Z-EDI和Z-EDIII重组抗原在恢复期晚期能血清学区分寨卡病毒感染与登革病毒感染。
- Z-EDIII抗原有望用于人群监测和检测既往寨卡病毒感染。
研究设计与样本
- 基于寨卡病毒包膜蛋白的比较表位建模设计两种重组抗原Z-EDI和Z-EDIII。
主要发现
- Z-EDI和Z-EDIII抗原在感染后>12周的恢复期晚期一致检测寨卡病毒特异性IgG,而不与登革病毒免疫血清交叉反应。
- 感染后2至12周的恢复期早期,继发性登革病毒免疫血清和部分原发性登革病毒免疫血清与Z-EDI和Z-EDIII抗原交叉反应。
- 对登革病毒免疫个体连续样本分析显示,Z-EDIII交叉反应在恢复期早期达峰并随时间迅速下降。
临床怎么用
- Z-EDIII抗原可用于人群-level监测和检测既往寨卡病毒感染。
- 在恢复期早期(2至12周)解读寨卡血清学结果时需注意与登革病毒的交叉反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zika virus (ZIKV) is an emerging flavivirus that can cause birth defects and neurologic complications. Molecular tests are effective for diagnosing acute ZIKV infection, although the majority of infections produce no symptoms at all or present after the narrow window in which molecular diagnostics are dependable. Serology is a reliable method for detecting infections after the viremic period; however, most serological assays have limited specificity due to cross-reactive antibodies elicited by flavivirus infections. Since ZIKV and dengue virus (DENV) widely cocirculate, distinguishing ZIKV infection from DENV infection is particularly important for diagnosing individual cases or for surveillance to coordinate public health responses. Flaviviruses also elicit type-specific antibodies directed to non-cross-reactive epitopes of the infecting virus; such epitopes are attractive targets for the design of antigens for development of serological tests with greater specificity. Guided by comparative epitope modeling of the ZIKV envelope protein, we designed two recombinant antigens displaying unique antigenic regions on domain I (Z-EDI) and domain III (Z-EDIII) of the ZIKV envelope protein. Both the Z-EDI and Z-EDIII antigens consistently detected ZIKV-specific IgG in ZIKV-immune sera but not cross-reactive IgG in DENV-immune sera in late convalescence (>12 weeks postinfection). In contrast, during early convalescence (2 to 12 weeks postinfection), secondary DENV-immune sera and some primary DENV-immune sera cross-reacted with the Z-EDI and Z-EDIII antigens. Analysis of sequential samples from DENV-immune individuals demonstrated that Z-EDIII cross-reactivity peaked in early convalescence and declined steeply over time. The Z-EDIII antigen has much potential as a diagnostic antigen for population-level surveillance and for detecting past infections in patients.
引用
- Premkumar L, Collins M, Graham S, et al. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection. J Clin Microbiol. 2018. PMID: 29263206. doi:10.1128/JCM.01504-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。